(Reuters) – Abbott Laboratories said on Friday that the U.S. Food and Drug Administration granted emergency use authorization for its molecular test to detect and distinguish the coronavirus and two types of flu viruses in a single test.
The test, Alinity m Resp-4-Plex, is an important tool because these viruses have similar symptoms but require different treatment approaches, the company said.
Source: Read Full Article